Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1375 (LINC01375) is a member of the long intergenic non-coding RNA (lincRNA) family, which are RNA molecules longer than 200 nucleotides that do not code for proteins and do not overlap with protein-coding regions[1][3][5]. LincRNAs are increasingly recognized as important regulators of gene expression, acting through mechanisms such as chromatin remodeling, transcription modulation, and RNA stability, with many displaying tissue-specific functions. While thousands of lincRNAs have been annotated, only a small subset have been well characterized, and their roles often involve fine-tuning gene expression, particularly in disease contexts including cancer[5][7]. LINC01375 itself has not been specifically characterized as a therapeutic target, and there are no known drugs or well-validated biomarker roles associated with it at this time[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1375 (LINC01375).